GSA Capital Partners LLP Increases Stock Holdings in Phreesia, Inc. (NYSE:PHR)

GSA Capital Partners LLP boosted its holdings in shares of Phreesia, Inc. (NYSE:PHR) by 418.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 49,553 shares of the company’s stock after acquiring an additional 39,993 shares during the period. GSA Capital Partners LLP owned 0.09% of Phreesia worth $1,129,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in PHR. International Assets Investment Management LLC lifted its stake in Phreesia by 2,179.7% during the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after acquiring an additional 1,395 shares during the period. nVerses Capital LLC raised its position in shares of Phreesia by 76.5% during the second quarter. nVerses Capital LLC now owns 3,000 shares of the company’s stock valued at $64,000 after buying an additional 1,300 shares during the last quarter. EntryPoint Capital LLC purchased a new stake in shares of Phreesia in the first quarter worth about $169,000. Quadrature Capital Ltd bought a new stake in Phreesia in the 1st quarter worth approximately $202,000. Finally, Lombard Odier Asset Management USA Corp purchased a new stake in Phreesia during the second quarter valued at $202,000. 92.10% of the stock is owned by institutional investors.

Insider Activity

In other Phreesia news, CFO Balaji Gandhi sold 3,502 shares of the business’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $23.25, for a total transaction of $81,421.50. Following the completion of the sale, the chief financial officer now owns 98,578 shares in the company, valued at $2,291,938.50. The trade was a 3.43 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, General Counsel Allison C. Hoffman sold 1,212 shares of Phreesia stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $21.03, for a total value of $25,488.36. Following the sale, the general counsel now directly owns 119,791 shares in the company, valued at approximately $2,519,204.73. This trade represents a 1.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 44,107 shares of company stock valued at $1,035,226 in the last ninety days. Company insiders own 5.80% of the company’s stock.

Analysts Set New Price Targets

PHR has been the subject of several recent analyst reports. Robert W. Baird boosted their target price on Phreesia from $31.00 to $34.00 and gave the company an “outperform” rating in a research report on Friday, September 6th. JMP Securities restated a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a research note on Thursday, September 5th. JPMorgan Chase & Co. upped their price objective on shares of Phreesia from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Monday, September 9th. Truist Financial lifted their price target on Phreesia from $29.00 to $31.00 and gave the stock a “buy” rating in a research report on Friday, September 6th. Finally, DA Davidson reaffirmed a “buy” rating and issued a $32.00 price objective on shares of Phreesia in a report on Thursday, September 5th. One equities research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat.com, Phreesia currently has a consensus rating of “Moderate Buy” and a consensus target price of $29.42.

Phreesia Trading Down 6.1 %

NYSE:PHR opened at $20.99 on Friday. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.77 and a current ratio of 1.77. Phreesia, Inc. has a 1 year low of $14.55 and a 1 year high of $29.16. The stock has a fifty day moving average price of $21.49 and a two-hundred day moving average price of $22.04. The stock has a market capitalization of $1.21 billion, a price-to-earnings ratio of -12.09 and a beta of 0.94.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Wednesday, September 4th. The company reported ($0.31) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.06. The business had revenue of $102.12 million during the quarter, compared to analysts’ expectations of $101.76 million. Phreesia had a negative net margin of 25.73% and a negative return on equity of 39.34%. As a group, sell-side analysts anticipate that Phreesia, Inc. will post -1.23 earnings per share for the current fiscal year.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.